Determination That PHENAPHEN WITH CODEINE NO. 3 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 30 Milligrams, and PHENAPHEN WITH CODEINE NO. 4 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 60 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA or Agency) has determined that PHENAPHEN WITH CODEINE NO. 3 (acetaminophen; codeine phosphate) oral capsules, 325 milligrams (mg) and 30 mg, and PHENAPHEN WITH CODEINE NO. 4 (acetaminophen; codeine phosphate) oral capsules, 325 mg and 60 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for PHENAPHEN WITH CODEINE NO. 3 (acetaminophen; codeine phosphate) oral capsules, 325 mg and 30 mg, and PHENAPHEN WITH CODEINE NO. 4 (acetaminophen; codeine phosphate) oral capsules, 325 mg and 60 mg, if all other legal and regulatory requirements are met.

created_at
provider_category
Notice
created_by
scheduled-job:a5bbbe5ddcbdd49aeae94c04e3e1fefe5._scheduled_job.98281506-8306-45a9-b190-5e32261f7ddd
providers
federal_register
text_url
https://www.federalregister.gov/documents/full_text/text/2026/09/03/2026-18023.txt
source
Federal Register
themes
government, policy, regulation
provider_count
1
source_slug
federal-register
url
https://www.federalregister.gov/documents/2026/09/03/2026-18023/determination-that-phenaphen-with-codeine-no-3-acetaminophen-codeine-phosphate-oral-capsules-325
country
United States
language
English
org_id
0ac7c1ae-d6eb-4868-9eb4-96b085d4f7ba
dedup_key
f6afc4514dc89e2ed6f4b4864b2c082f1765da4e590f3f799e315fdbd5855b0d
last_modified_at
provider
federal_register
last_modified_by
scheduled-job:a5bbbe5ddcbdd49aeae94c04e3e1fefe5._scheduled_job.98281506-8306-45a9-b190-5e32261f7ddd
feed_section
Government
published_at

Related